>> Continued From the Previous Page <<
James reacted swiftly, issuing a 10-day ultimatum demanding the program be reinstated. She also floated potential legal action under New York’s anti-discrimination statutes.
But according to Blanche, that argument doesn’t hold up under scrutiny.
“NYU Langone’s exercise of its sound discretion to not provide such services and procedures does not constitute discrimination on any of these grounds,” Blanche wrote.
A Legal Argument on Shaky Ground
At the heart of James’ position is the claim that ending the program violates protections based on sex, gender identity, and disability.
However, the DOJ pushed back, emphasizing a key distinction.
NYU Langone did not deny care to individuals based on who they are. Instead, the hospital made a medical and administrative decision to discontinue a specific set of treatments—a routine type of decision made across healthcare systems every day.
That difference matters.
Anti-discrimination laws are designed to prevent denial of access to patients—not to force providers to offer particular treatments. Attempting to stretch those laws into a mandate for specific procedures could face serious legal hurdles.
Notably, James’ own deadline passed without action. The hospital did not reinstate the program, and no lawsuit was filed.
Supreme Court Precedent Looms Large
The situation becomes even more complicated for James when viewed in light of a recent Supreme Court ruling.
In United States v. Skrmetti, the Court ruled 6-3 that states can restrict puberty blockers and hormone treatments for minors without violating the Equal Protection Clause.
Chief Justice John Roberts, writing for the majority, explained that such laws are based on age and medical diagnosis—not transgender status.
That reasoning directly undercuts the foundation of James’ argument.
Blanche highlighted this point, noting that NYU Langone’s policy is tied to diagnosis rather than identity. In other words, the hospital’s decision does not single out transgender individuals but instead reflects a broader medical judgment.
Deadline Passes—But No Lawsuit Follows
James initially issued her ultimatum on February 25, giving the hospital until March 11 to comply or face consequences.
That deadline came and went quietly.
NYU Langone stood firm. No program was reinstated. And despite the earlier threats, James did not file suit.
The silence speaks volumes.
With the DOJ now publicly backing the hospital—and a recent Supreme Court decision reinforcing the legal framework—James would be stepping into a difficult fight with significant risks.
A Political Strategy Meets Legal Reality
Critics argue that this episode follows a familiar pattern: high-profile threats, media attention, and then a quiet retreat when challenged.
Earlier efforts appeared to yield quick concessions. This time, however, the response was different.
NYU Langone held its ground.
And the federal government stepped in.
Blanche made it clear that the DOJ “will not sit idly by” if James proceeds—signaling that any legal battle would likely dismantle her argument under established precedent.
A Standoff That Didn’t Materialize
For now, the situation has reached a standstill.
James’ deadline has expired. The hospital has not reversed course. And the anticipated lawsuit has yet to appear.
What began as a high-stakes confrontation has instead turned into a cautionary example of how legal overreach can collide with constitutional limits—and lose momentum before ever reaching the courtroom.
